Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
79
SPFI Quote, Financials, Valuation and Earnings
Last price:
$40.69
Seasonality move
:
9.79%
Day range:
$37.57 - $40.74
52-week range:
$29.36 - $40.91
Dividend yield:
1.45%
P/E ratio:
12.69x
P/S ratio:
3.47x
P/B ratio:
1.45x
Volume:
227K
Avg. volume:
56.1K
1-year change:
29.3%
Market cap:
$659M
Revenue:
$189.3M
EPS (TTM):
$3.20
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $219.6M | $214.2M | $209.2M | $176.2M | $189.3M | |
| Revenue Growth (YoY) | 39.13% | -2.46% | -2.33% | -15.78% | 7.42% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $92.3M | $96.6M | $89.9M | $82.8M | $78.1M | |
| Other Inc / (Exp) | $2.3M | -- | -- | $30.4M | -- | |
| Operating Expenses | $92.3M | $96.6M | $89.9M | $116.6M | $78.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $56.6M | $73.1M | $73.2M | $79.4M | $63.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11.3M | $14.5M | $14.9M | $16.7M | $13.6M | |
| Net Income to Company | $45.4M | $58.6M | $58.2M | $62.7M | $49.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $45.4M | $58.6M | $58.2M | $62.7M | $49.7M | |
| Basic EPS (Cont. Ops) | $2.51 | $3.26 | $3.35 | $3.73 | $3.03 | |
| Diluted EPS (Cont. Ops) | $2.47 | $3.17 | $3.23 | $3.62 | $2.92 | |
| Weighted Average Basic Share | $18.1M | $18M | $17.4M | $16.8M | $16.4M | |
| Weighted Average Diluted Share | $18.3M | $18.5M | $18M | $17.3M | $17M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $72.5M | $86.4M | $95.8M | $151.7M | $157.1M | |
| Revenue (Reported) | $219.6M | $214.2M | $209.2M | $176.2M | $189.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $72.5M | $86.4M | $95.8M | $151.7M | $157.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $55M | $52.3M | $43.7M | $45.4M | $47.7M | |
| Revenue Growth (YoY) | 14.52% | -4.86% | -16.57% | 3.95% | 5.11% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24.9M | $23.4M | $20.2M | $19.7M | $20.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $24.9M | $23.4M | $20.2M | $19.7M | $20.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $18.9M | $17.8M | $11.6M | $14M | $15.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | $3.5M | $2.4M | $3.1M | $3.4M | |
| Net Income to Company | $15.2M | $14.3M | $9.2M | $10.9M | $12.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $15.2M | $14.3M | $9.2M | $10.9M | $12.3M | |
| Basic EPS (Cont. Ops) | $0.84 | $0.81 | $0.54 | $0.66 | $0.75 | |
| Diluted EPS (Cont. Ops) | $0.82 | $0.78 | $0.53 | $0.64 | $0.72 | |
| Weighted Average Basic Share | $18.1M | $17.7M | $17M | $16.4M | $16.4M | |
| Weighted Average Diluted Share | $18.5M | $18.4M | $17.6M | $16.9M | $17.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22.3M | $20.9M | $24.8M | $37.4M | $37.1M | |
| Revenue (Reported) | $55M | $52.3M | $43.7M | $45.4M | $47.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22.3M | $20.9M | $24.8M | $37.4M | $37.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $226.6M | $211.6M | $200.6M | $178M | $191.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $95.6M | $95.1M | $86.7M | $82.4M | $78.7M | |
| Other Inc / (Exp) | -- | -- | -- | $30.4M | -- | |
| Operating Expenses | $95.6M | $95.1M | $86.7M | $116.2M | $78.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $66.7M | $72M | $67M | $81.8M | $65M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.2M | $14.3M | $13.8M | $17.4M | $13.8M | |
| Net Income to Company | $53.4M | $57.7M | $53.2M | $64.4M | $51.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $53.4M | $57.7M | $53.2M | $64.4M | $51.1M | |
| Basic EPS (Cont. Ops) | $2.96 | $3.24 | $3.08 | $3.83 | $3.12 | |
| Diluted EPS (Cont. Ops) | $2.92 | $3.13 | $2.98 | $3.74 | $3.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $80.5M | $85M | $99.7M | $164.3M | $156.8M | |
| Revenue (Reported) | $226.6M | $211.6M | $200.6M | $178M | $191.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $80.5M | $85M | $99.7M | $164.3M | $156.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $55M | $52.3M | $43.7M | $45.4M | $47.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $24.9M | $23.4M | $20.2M | $19.7M | $20.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $24.9M | $23.4M | $20.2M | $19.7M | $20.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $18.9M | $17.8M | $11.6M | $14M | $15.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | $3.5M | $2.4M | $3.1M | $3.4M | |
| Net Income to Company | $15.2M | $14.3M | $9.2M | $10.9M | $12.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $15.2M | $14.3M | $9.2M | $10.9M | $12.3M | |
| Basic EPS (Cont. Ops) | $0.84 | $0.81 | $0.54 | $0.66 | $0.75 | |
| Diluted EPS (Cont. Ops) | $0.82 | $0.78 | $0.53 | $0.64 | $0.72 | |
| Weighted Average Basic Share | $18.1M | $17.7M | $17M | $16.4M | $16.4M | |
| Weighted Average Diluted Share | $18.5M | $18.4M | $17.6M | $16.9M | $17.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $22.3M | $20.9M | $24.8M | $37.4M | $37.1M | |
| Revenue (Reported) | $55M | $52.3M | $43.7M | $45.4M | $47.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $22.3M | $20.9M | $24.8M | $37.4M | $37.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $300.3M | $486.8M | $234.9M | $330.2M | $359.1M | |
| Short Term Investments | $803.1M | $724.5M | $701.7M | $183.9M | $268.2M | |
| Accounts Receivable, Net | $15.2M | $13.9M | $16.4M | $20.9M | $21.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.1B | $1.2B | $953M | $534.9M | $649M | |
| Property Plant And Equipment | $60.3M | $57.7M | $56.3M | $55.1M | $53M | |
| Long-Term Investments | $803.1M | $724.5M | $701.7M | $183.9M | $268.2M | |
| Goodwill | $19.5M | $19.5M | $19.5M | $19.3M | $19.3M | |
| Other Intangibles | $16.6M | $25.6M | $31.8M | $29M | $28M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.6B | $3.9B | $3.9B | $4.2B | $4.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $26.6M | -- | -- | -- | -- | |
| Long-Term Debt | $197M | $122.2M | $122.4M | $110.2M | $110.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.2B | $3.5B | $3.6B | $3.8B | $3.8B | |
| Common Stock | $18.1M | $17.8M | $17M | $16.4M | $16.5M | |
| Other Common Equity Adj | $21.3M | $13.7M | -$65.1M | -$51.7M | -$60.6M | |
| Common Equity | $370M | $407.4M | $357M | $407.1M | $438.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $370M | $407.4M | $357M | $407.1M | $438.9M | |
| Total Liabilities and Equity | $3.6B | $3.9B | $3.9B | $4.2B | $4.2B | |
| Cash and Short Terms | $1.1B | $1.2B | $936.6M | $514M | $627.3M | |
| Total Debt | $197M | $122.2M | $122.4M | $110.2M | $110.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $413.4M | $528.6M | $328M | $371.9M | $536.3M | |
| Short Term Investments | $777.2M | $793.4M | $698.6M | $599.9M | $217.3M | |
| Accounts Receivable, Net | $11.3M | $10.5M | $14.4M | $16.6M | $17.7M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.2B | $1.3B | $1B | $988.4M | $771.4M | |
| Property Plant And Equipment | $59.2M | $57.4M | $56.1M | $54.2M | $50.9M | |
| Long-Term Investments | $777.2M | $793.4M | $698.6M | $599.9M | $217.3M | |
| Goodwill | $19.5M | $19.5M | $19.5M | $19.3M | $19.3M | |
| Other Intangibles | $20.7M | $30.9M | $29.8M | $29.1M | $26.5M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3.7B | $4B | $4.1B | $4.2B | $4.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $17.5M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $17.5M | -- | -- | -- | -- | |
| Long-Term Debt | $147M | $122.2M | $122.4M | $110.2M | $110.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.4B | $3.6B | $3.7B | $3.8B | $4B | |
| Common Stock | $18.1M | $17.7M | $17.1M | $16.4M | $16.2M | |
| Other Common Equity Adj | $12.2M | -$16.3M | -$60.4M | -$59.1M | -$57.9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $374.7M | $387.1M | $368M | $408.7M | $443.7M | |
| Total Liabilities and Equity | $3.7B | $4B | $4.1B | $4.2B | $4.4B | |
| Cash and Short Terms | $1.2B | $1.3B | $1B | $971.8M | $753.6M | |
| Total Debt | $164.6M | $122.2M | $122.4M | $110.2M | $110.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $45.4M | $58.6M | $58.2M | $62.7M | $49.7M | |
| Depreciation & Amoritzation | $6.6M | $6.4M | $7M | $6.4M | $6.5M | |
| Stock-Based Compensation | $1.3M | $1.6M | $2.8M | $2.2M | $2.3M | |
| Change in Accounts Receivable | -$3.1M | $3.4M | -$1.1M | -$8.5M | $1.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.6M | $96.3M | $123.6M | $58.5M | $59.4M | |
| Capital Expenditures | $3.3M | $2.9M | $4.5M | $4.7M | $3.4M | |
| Cash Acquisitions | -$687K | -- | -- | $36.1M | -- | |
| Cash From Investing | -$156.2M | -$159.8M | -$408.9M | -$143.4M | -$13.9M | |
| Dividends Paid (Ex Special Dividend) | -$2.5M | -$5.4M | -$8M | -$8.7M | -$9.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $124.1M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$105.6M | -$75M | -- | -$12.4M | -- | |
| Repurchase of Common Stock | -$293K | -$9.2M | -$22.7M | -$17.8M | -$1.3M | |
| Other Financing Activities | -$319K | -$625K | -$1.2M | -$731K | -$759K | |
| Cash From Financing | $292.8M | $250.1M | $33.3M | $180.1M | -$16.5M | |
| Beginning Cash (CF) | $158.1M | $300.3M | $486.8M | $234.9M | $330.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $142.2M | $186.5M | -$251.9M | $95.3M | $28.9M | |
| Ending Cash (CF) | $300.3M | $486.8M | $234.9M | $330.2M | $359.1M | |
| Levered Free Cash Flow | $2.3M | $93.4M | $119.1M | $53.9M | $56M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.2M | $14.3M | $9.2M | $10.9M | $12.3M | |
| Depreciation & Amoritzation | $1.6M | $1.7M | $1.7M | $1.6M | $1.5M | |
| Stock-Based Compensation | $390K | $528K | $525K | $481K | $569K | |
| Change in Accounts Receivable | -$418K | $2M | $609K | $6.5M | $6.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8.1M | $70.6M | $25.4M | $19.2M | $26.1M | |
| Capital Expenditures | $90K | $1.3M | $1.6M | $474K | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.5M | -$132.6M | -$31.3M | $12.5M | -$9.8M | |
| Dividends Paid (Ex Special Dividend) | -$904K | -$2M | -$2.2M | -$2.1M | -$2.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$59M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$786K | -$3M | -- | -$35K | -$8.3M | |
| Other Financing Activities | -$106K | -$195K | -$343K | -$132K | -$262K | |
| Cash From Financing | $120.5M | $103.8M | $99.1M | $10.1M | $160.9M | |
| Beginning Cash (CF) | $300.3M | $486.8M | $234.9M | $330.2M | $359.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $113.1M | $41.8M | $93.1M | $41.8M | $177.2M | |
| Ending Cash (CF) | $413.4M | $528.6M | $328M | $371.9M | $536.3M | |
| Levered Free Cash Flow | $8.1M | $69.3M | $23.8M | $18.7M | $25M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $53.4M | $57.7M | $53.2M | $64.4M | $51.1M | |
| Depreciation & Amoritzation | $6.6M | $6.5M | $7M | $6.3M | $6.4M | |
| Stock-Based Compensation | $1.4M | $1.8M | $2.8M | $2.1M | $2.4M | |
| Change in Accounts Receivable | -$570K | $5.8M | -$2.5M | -$2.6M | $1.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.5M | $158.7M | $78.3M | $52.3M | $66.3M | |
| Capital Expenditures | $2.2M | $4.1M | $4.7M | $3.6M | $4M | |
| Cash Acquisitions | -$687K | -- | -- | $36.1M | -- | |
| Cash From Investing | -$196.8M | -$276.9M | -$307.6M | -$99.6M | -$36.2M | |
| Dividends Paid (Ex Special Dividend) | -$2.9M | -$6.4M | -$8.3M | -$8.7M | -$9.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$144.9M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$1.1M | -$11.5M | -$19.7M | -$17.8M | -$9.6M | |
| Other Financing Activities | -$341K | -$714K | -$1.3M | -$520K | -$889K | |
| Cash From Financing | $464.7M | $233.4M | $28.6M | $91.2M | $134.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $277.3M | $115.2M | -$200.6M | $43.9M | $164.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.2M | $154.6M | $73.6M | $48.7M | $62.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.2M | $14.3M | $9.2M | $10.9M | $12.3M | |
| Depreciation & Amoritzation | $1.6M | $1.7M | $1.7M | $1.6M | $1.5M | |
| Stock-Based Compensation | $390K | $528K | $525K | $481K | $569K | |
| Change in Accounts Receivable | -$418K | $2M | $609K | $6.5M | $6.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8.1M | $70.6M | $25.4M | $19.2M | $26.1M | |
| Capital Expenditures | $90K | $1.3M | $1.6M | $474K | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15.5M | -$132.6M | -$31.3M | $12.5M | -$9.8M | |
| Dividends Paid (Ex Special Dividend) | -$904K | -$2M | -$2.2M | -$2.1M | -$2.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$59M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$786K | -$3M | -- | -$35K | -$8.3M | |
| Other Financing Activities | -$106K | -$195K | -$343K | -$132K | -$262K | |
| Cash From Financing | $120.5M | $103.8M | $99.1M | $10.1M | $160.9M | |
| Beginning Cash (CF) | $300.3M | $486.8M | $234.9M | $330.2M | $359.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $113.1M | $41.8M | $93.1M | $41.8M | $177.2M | |
| Ending Cash (CF) | $413.4M | $528.6M | $328M | $371.9M | $536.3M | |
| Levered Free Cash Flow | $8.1M | $69.3M | $23.8M | $18.7M | $25M | |
Get SPFI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SPFI
Sector
P/E ratio
12.69x
12.21x
PEG ratio
0.67x
0.40x
P/B ratio
1.45x
1.11x
Price / LTM sales
3.47x
2.66x
Growth Metrics
SPFI
Sector
Revenue growth
16.12%
5.12%
Earnings growth
30.3%
2.63%
Revenue (5-year growth)
3.7%
5.17%
Earnings forecast
$0.77
$0.61
Profitability
SPFI
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
9.93%
5.21%
Return on assets
1.27%
0.97%
Return on equity
12.42%
9.24%
Earnings Date
Last Earnings Date
Jul
16
Next Earnings Date
Oct
23
Estimated Next Earnings Date
Oct
15
Balance Sheet
SPFI
Sector
Total cash
$1B
$451.2M
Short term investments
$268.2M
$220.9M
Total assets
$4.2B
$3.8B
Long term debt
$111.8M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
